Human breath could help identify cancerous lung nodules and reduce the need for invasive testing. New Griffith University research analyzed exhaled breath to help doctors distinguish between cancerous ...
A simple breath test could help doctors determine whether suspicious lung nodules are cancerous without immediately turning ...
InvestorsHub on MSN
BioAffinity Technologies to showcase lung cancer test data at veterans’ research conference
Affinity Technologies (NASDAQ:BIAF) will present new clinical findings on its noninvasive lung cancer test, CyPath® Lung, at the 2026 NAVREF Annual Conference, running September 27–30 in Arlington, ...
SAN ANTONIO, Texas--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...
According to the former Fierce 15 winner, the test’s sensitivity was able to deliver a negative predictive value of 99.7%, or a 3-in-1,000 chance of lung cancer with a negative result. (Cecilia ...
Share on Pinterest A new screening test could help diagnose lung cancer earlier than traditional CT scans. Andriy Onufriyenko/Getty Images About 1.8 million deaths each year are attributable to lung ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results